Silence Therapeutics plc (SLN) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$6.05
Day's range
$6.54

Silence Therapeutics Plc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
SIREN, L.L.C. 08/13/2026 3.31 M $36.36 M   13.74% 21.03%
TCG CROSSOVER MANAGEMENT, LLC 08/14/2026 3.03 M $33.31 M   0.00% 19.27%
REDMILE GROUP, LLC 08/14/2026 2.16 M $23.77 M   0.00% 13.75%
NANTAHALA CAPITAL MANAGEMENT, LLC 08/19/2026 1.35 M $14.79 M   -37.27% 8.55%
CITADEL ADVISORS LLC 09/02/2026 1.33 M $14.60 M   7.68% 8.44%
NEXTECH INVEST, LTD. 08/14/2026 952.40 K $10.46 M   0.00% 6.05%
MILLENNIUM MANAGEMENT LLC 08/14/2026 909.28 K $9.98 M   -15.35% 5.77%
IKARIAN CAPITAL, LLC 08/14/2026 830.78 K $1.83 M   -4.04% 5.28%
TFG ASSET MANAGEMENT GP LTD 08/13/2026 764.26 K $8.39 M   21.28% 4.85%
SOLEUS CAPITAL MANAGEMENT, L.P. 08/11/2026 630.00 K $6.92 M   100.00% 4.00%
BALYASNY ASSET MANAGEMENT L.P. 08/14/2026 610.98 K $6.71 M   100.00% 3.88%
5AM VENTURE MANAGEMENT, LLC 08/14/2026 476.20 K $5.23 M   0.00% 3.02%
GREAT POINT PARTNERS LLC 08/14/2026 450.00 K $4.94 M   -55.90% 2.86%
MORGAN STANLEY 08/13/2026 403.17 K $4.43 M   515.66% 2.56%
AMERIPRISE FINANCIAL INC 08/14/2026 370.05 K $4.06 M   100.00% 2.35%
JANE STREET GROUP, LLC 08/14/2026 369.15 K $4.05 M   265.76% 2.34%
ADAR1 CAPITAL MANAGEMENT, LLC 08/14/2026 338.37 K $3.72 M   96.55% 2.15%
SUMMITTX CAPITAL, L.P. 08/14/2026 326.65 K $3.59 M   100.00% 2.07%
TFG ASSET MANAGEMENT GP LTD 08/13/2026 300.00 K $3.29 M   100.00% 1.91%
CAPTION MANAGEMENT, LLC 08/14/2026 297.90 K $3.27 M   100.00% 1.89%
SCHONFELD STRATEGIC ADVISORS LLC 08/14/2026 269.35 K $2.96 M   100.00% 1.71%
UBS GROUP AG 08/13/2026 243.15 K $2.67 M   -1.53% 1.54%
BLACKROCK, INC. 08/07/2026 219.92 K $2.41 M   7.39% 1.40%
BANK OF MONTREAL /CAN/ 08/12/2026 201.73 K $2.22 M   -0.58% 1.28%
BOOTHBAY FUND MANAGEMENT, LLC 08/14/2026 198.35 K $2.18 M   -5.14% 1.26%
PROPEL BIO MANAGEMENT, LLC 08/13/2026 191.73 K $2.11 M   100.00% 1.22%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 184.52 K $2.03 M   60.06% 1.17%
FRED ALGER MANAGEMENT, LLC 08/14/2026 177.00 K $1.94 M   100.00% 1.12%
QUBE RESEARCH & TECHNOLOGIES LTD 08/14/2026 163.95 K $1.80 M   56.80% 1.04%
CAPTION MANAGEMENT, LLC 08/14/2026 162.48 K $1.78 M   100.00% 1.03%
BNP PARIBAS ARBITRAGE, SNC 08/13/2026 158.95 K $1.75 M   7.64% 1.01%
GOLDMAN SACHS GROUP INC 08/14/2026 155.93 K $1.71 M   196.95% 0.99%
HSBC HOLDINGS PLC 08/14/2026 122.83 K $1.32 M   0.00% 0.78%
TWO SIGMA INVESTMENTS, LP 08/14/2026 121.00 K $1.33 M   646.80% 0.77%
QUADRATURE CAPITAL LTD 08/07/2026 118.13 K $1.30 M   100.00% 0.75%
SQUAREPOINT OPS LLC 08/14/2026 115.92 K $1.27 M   29.56% 0.74%
XTX TOPCO LTD 08/14/2026 107.58 K $1.18 M   1.49% 0.68%
M28 CAPITAL MANAGEMENT LP 08/13/2026 101.20 K $1.11 M   0.00% 0.64%
MARSHALL WACE, LLP 08/13/2026 72.04 K $790.99 K   -57.53% 0.46%
BIRCHVIEW CAPITAL, LP 08/14/2026 71.22 K $781.97 K   100.00% 0.45%
SEVEN FLEET CAPITAL MANAGEMENT LP 08/17/2026 60.11 K $659.98 K   -61.66% 0.38%
ISHARA INVESTMENTS LP 08/14/2026 55.35 K $2.43 M   -60.61% 0.35%
HRT FINANCIAL LP 08/14/2026 30.75 K $337.00 K   156.36% 0.20%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 29.80 K $327.20 K   47.52% 0.19%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 29.54 K $324.33 K   0.00% 0.19%
VIRTU FINANCIAL LLC 08/13/2026 25.64 K $282.00 K   100.00% 0.16%
BANK OF AMERICA CORP /DE/ 08/14/2026 25.28 K $277.57 K   -15.09% 0.16%
TREXQUANT INVESTMENT LP 08/14/2026 23.84 K $261.79 K   100.00% 0.15%
VERDAD ADVISERS, LP 08/14/2026 20.40 K $223.99 K   100.00% 0.13%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 19.40 K $213.01 K   2.65% 0.12%

Silence Therapeutics Plc institutional Ownership - FAQ's

During the previous two years, 80 institutional investors and hedge funds held shares of Silence Therapeutics Plc. The most heavily invested institutionals were:

Siren, L.L.C.: 3.31 M

TCG Crossover Management, LLC: 3.03 M

Redmile Group, LLC: 2.16 M

Nantahala Capital Management, LLC: 1.35 M

CITADEL ADVISORS LLC: 1.33 M

Nextech Invest, Ltd.: 952,400

141.23% of Silence Therapeutics Plc stock is owned by institutional investors.

Institutional investors have bought a total of 23.21 M shares in the last 24 months. This purchase volume represents approximately $143.64 M in transactions.